The emergence of Retatrutide ZPHC, at a dosage of 120mg, is generating considerable excitement within the weight loss community. This innovative dual GIP and GLP-1 agonist medication appears to offer notable improvements in weight shedding compared to existing therapies. Preliminary clinical studies have indicated marked reductions in body fat perc